Peer support program for young cancer patients
Evaluation of a Peer Supported Program for Adolescent and Young Adult Cancer Patients
This study tests if a mentoring program that connects young cancer patients with survivors can help improve their emotional well-being and quality of life.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 180 (estimated) |
| Ages | 18 Years to 39 Years |
| Sex | All |
| Sponsor | University of Leipzig Academic / other |
| Locations | 2 sites (Leipzig, Saxony and 1 other locations) |
| Trial ID | NCT05336318 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of the 'Peer2Me' mentoring program, which pairs acutely ill adolescent and young adult cancer patients with mentors who have survived similar experiences. Over three months, participants in the intervention group receive support from their mentors, while the control group receives a one-time consultation. The study measures psychosocial distress and quality of life before, immediately after, and three months post-intervention using standardized questionnaires. The goal is to assess the impact of peer mentoring on psychological well-being and social support.
Who should consider this trial
Good fit: Ideal candidates are adolescents and young adults aged 18 to 39 who have been diagnosed with cancer within the last six months.
Not a fit: Patients with existing psychiatric conditions or those undergoing palliative treatment may not benefit from this program.
Why it matters
Potential benefit: If successful, this program could significantly improve the psychosocial well-being of young cancer patients through peer support.
How similar studies have performed: Previous studies have shown positive outcomes with peer support interventions in similar populations, indicating potential for success in this approach.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Cancer disease between the ages of 18 and 39 (all tumor entities) * completion of acute treatment at least 2 years ago (mentors) * curative prognosis * Native language German or fluent German speaker * first cancer diagnosis in the last 6 months (mentees, all tumor entities) * curative prognosis Exclusion Criteria: * existing and already diagnosed psychiatric disease, ongoing psychotherapy and/or existing suicidal tendency * palliative treatment approach
Where this trial is running
Leipzig, Saxony and 1 other locations
- University Medical Center Leipzig — Leipzig, Saxony, Germany (Recruiting)
- University Medical Center Hamburg-Eppendorf, Department of Medical Psychology — Hamburg, Germany (Recruiting)
Study contacts
- Principal investigator: Diana Richter, PhD. — Universitätsklinikum Leipzig
- Study coordinator: Diana Richter, PhD.
- Email: diana.richter@medizin.uni-leipzig.de
- Phone: +493419715438
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.